Bill · H.R. 1463· House(119-HR-1463)
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.
- Introduced
- 2/21/2025
- Last activity
- 2/21/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Brad Finstad
- Cosponsors
- - 7 - 0
- Introduced
- In Committee
What this bill would do
This bill aims to prohibit the use of Federal funds for certain Food and Drug Administration activities. Specifically, it stops money from being used to implement, administer, or enforce a final rule regarding "Medical Devices; Laboratory Developed Tests." This rule was submitted for publication in the Federal Register on May 6, 2024. The bill also applies to any rule that is substantially similar to that one.
Yes
Would business owners be better off under this?+3
The bill benefits diagnostic laboratories and medical device companies by preventing the enforcement of new regulatory requirements for laboratory developed tests.
The opposite
Does this give the federal government more power?-2
The bill limits the regulatory power of a federal agency by prohibiting the use of funds to enforce a specific rule.
Does this make health care easier to get in general?-2
The bill may hinder healthcare access by preventing the regulation and oversight of laboratory developed tests.
Does this reduce what the federal government spends?-1
The bill reduces government spending by prohibiting the use of Federal funds for the enforcement of the specified FDA rule.
Who it would affect, and how
Potential Positive Impacts for People
- Prevention of Rule Enforcement: By prohibiting Federal funds, the bill stops the implementation, administration, or enforcement of the final rule relating to "Medicals Devices; Laboratory Developed Tests" (Section 1).
Potential Negative Impacts for People
- Restriction of FDA Rule Implementation: The bill prevents the use of Federal funds to implement, administer, or enforce the specific Food and Drug Administration final rule submitted on May 6, 2024, or any substantially similar rule (Section 1).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Business Owners+3
- Governance And Ideology
- Increases Federal Power-2
- Healthcare
- Improves Healthcare Access-2
- Economy And Finance
- Reduces Government Spending-1
- 8/8/2025
- 1 Cosponsor added.
- 4/1/2025
- 1 Cosponsor added.
- 3/21/2025
- 1 Cosponsor added.
- 3/4/2025
- 1 Cosponsor added.
- 2/27/2025
- 1 Cosponsor added.
- 2/24/2025
- 1 Cosponsor added.
- 2/21/2025
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
- Introduced in House
Andy BarrRepublican · Kentucky
Dan CrenshawRepublican · Texas
Neal DunnRepublican · Florida
Craig GoldmanRepublican · Texas
Mariannette Miller-MeeksRepublican · Iowa
August PflugerRepublican · Texas
Randy WeberRepublican · Texas